Ординатура / Офтальмология / Английские материалы / Ocular Neuroprotection_Levin, Polo _2003
.pdf320 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Index |
Reactive oxygen species (ROS), 95, 96, |
pigment epithelium (RPE), 5, 94, 95, |
|||||||||||||
|
99, 236, 241 |
|
|
|
|
|
|
|
|
96, 99, 102, 111, 113, 116, 117, |
||||
Reaggregation, 7 |
|
|
|
|
|
|
|
|
|
118, 119, 121, 122, 123, 170, |
||||
cultures, 7 |
|
|
|
|
|
|
|
|
|
|
172, 175, 178, 179, 199, 200 |
|||
Recti muscle, 25, 26, 68, 132, 133 |
|
reattachment, 110, 114, 116, 117, |
||||||||||||
Retina, |
2, |
4, |
5, |
6, |
14, |
16, |
|
18, |
19, |
28, |
118, 121, 123 |
|||
|
54, 56, 58, 61, 62, 63, 64, 66, |
slice cultures, 6, 7 |
||||||||||||
|
68, 85, 86, 87, 95, 96, 97, 98, |
whole-mount, 18, 141, 142, 189, 191, |
||||||||||||
|
99, |
100, |
101, |
102, |
110, |
111, |
192, 193, 196, 201, 202, 205, |
|||||||
|
112, |
113, |
114, |
115, |
116, |
117, |
217, 220 |
|||||||
|
118, 119, 120, 121, 122, 123, |
Retinaldehyde, 119 |
||||||||||||
|
129, 130, 131, 132, 133, 135, |
Retinitis pigmentosa, 100, 168, 250, 297, 298 |
||||||||||||
|
136, 138, 139, 141, 142, 143, |
Retinocollicular, 130 |
||||||||||||
|
144, 145, 146, 147, 148, 153, |
Retinogeniculate, 64 |
||||||||||||
|
154, 155, 156, 157, 162, 167, |
Retinopexy, 110 |
||||||||||||
|
168, 169,172, 173, 175, 176, |
Retinorecipient, 132, 192 |
||||||||||||
|
178, 180, 189, 190, 191, 192, |
Retinotomy, 117 |
||||||||||||
|
193, 194, 195, 196, 197, 200, |
Retinotopic, 56 |
||||||||||||
|
201, 202, 205, 206, 207, 208, |
Retrobulbar, 15, 61, 113 |
||||||||||||
|
209, 210, 211, 212, 213, 214, |
Retrograde labeling, 16, 130, 132, 133, |
||||||||||||
|
215, |
216, |
217, |
218, |
219, |
220, |
139, 140, 192, 208, 209, 219, 242 |
|||||||
|
221, |
228, |
231, |
232, |
234, |
242, |
dyes, |
|||||||
|
249, 250, 251, 253, 255, 257, |
DAPI, 191, 232, 234, 238, 242, |
||||||||||||
|
258, |
260, |
265, |
266, |
267, |
269, |
243, 246, 247 |
|||||||
|
274, 275, 277, 278, 283, 299 |
DiAsp, 17, 19, 133, 139, 140, 142, |
||||||||||||
blood flow, 61, 62, 69, 131, 133, 134, |
143, 144 |
|||||||||||||
|
135, 136, 138, 146, 148, 155 |
|
DiI, 208 |
|||||||||||
detachment, 109, 110, 111, 112, 113, |
FluoroGold, 16, 17, 28, 132, 141, 142 |
|||||||||||||
|
114, 115, 116, 117, 118, 119, |
Retrolaminar, 66 |
||||||||||||
|
120, 121, 122, 123, 124, 156, |
Rhegmatogenous, 110, 111, 112, 117, |
||||||||||||
|
169 |
|
|
|
|
|
|
|
|
|
|
|
|
118, 121, 122, 123 |
ganglion cell (RGC), 4, 7, 8, 13, 14, |
Rhodamine, 236, 237 |
|||||||||||||
|
15, 16, 17, 18, 19, 23, 28, 54, |
Rhodopsin, 62, 87, 88, 89, 92, 93, 94, |
||||||||||||
|
57, 59, 61, 63, 129, 130, 131, |
96, 97, 99, 100, 102, 118, 119, |
||||||||||||
|
132, 133, 134, 136, 139, 140, |
168, 169, 175, 261 |
||||||||||||
|
141, 142, 143, 144, 145, 146, |
Ribozyme, 168 |
||||||||||||
|
147, 148, 161, 162, 169, 170, |
RNAse, 228, 231, 232, 235 |
||||||||||||
|
172, 175, 192, 205, 208, 209, |
Rod photoreceptors, 8, 117, 118, 121, |
||||||||||||
|
214, 217, 220, 231, 241, 242, |
190, 191, 198, 199, 200, 251, |
||||||||||||
|
243, 244, 245, 246, 247, 254, |
255, 277 |
||||||||||||
|
266, 275, 276, 299 |
|
|
|
|
|
Rose bengal, 122, 123 |
|||||||
cultures, 7 |
|
|
|
|
|
|
|
|
|
Rostral, 16 |
||||
ischemia, 69, 110, 129, 133, 134, |
|
Royal College of Surgeons (RCS) rat, |
||||||||||||
|
135, 136, 138, 140, 144, 146, |
87, 88, 96, 99, 169 |
||||||||||||
|
147, 148, 235 |
|
|
|
|
|
|
|
RPMI, 3 |
|||||
Index
Sampling, 61, 193, 194, 195, 196, 199, 200, 213, 219
Schlemm’s canal, 23, 27, 33, 34, 35, 38, 63, 71
SCID, 179
Sclera, 5, 25, 87, 113, 131, 136, 155, 156, 157, 158, 210, 211, 213, 217
Sclerosing, 34
Scotoma, 284
Scotopic, 54, 55, 95, 119, 120, 251, 252, 258, 260, 261, 262, 263, 264, 266
Secondary degeneration, 13, 283 Selenite, 3
Sialic acid, 3 Sigmoidal, 263, 264 Sildafil, 250 StatPac, 281, 282 Stereology, 193 Stereotactic, 16, 19
Subconjunctival, 26, 62, 157, 158 Subretinal, 110, 111, 112, 113, 114,
115, 116, 117, 121, 122, 172, 173, 175, 178, 179
Superior colliculi, 14, 16, 19, 131, 132, 141, 142, 172, 208, 242
Superoxide, 241, 242, 243, 244 Swedish Interactive Thresholding Algo-
rithm (SITA), 280 Synaptogenesis, 1 Synechiae, 51, 63, 72 Syneresis, 117
Tectum, 14
Tenon, 37, 155, 157, 158
Terminal deoxynucleotidyl transferase (TdT), 227, 228, 229, 230, 235
Tetrodotoxin, 56
Thermistor, 244 Thiols, 236
Timolol (Timoptic), 50, 51, 62, 155, 299 TMRM, 236
Tonography, 57
Tonometry, 40, 41, 42, 43, 50, 51
321
Tonopen, 27, 39, 40, 41, 42, 43, 51 TopSS, 52
Trabecular, 32, 33, 34, 38, 39, 48, 62, 63 Trabeculectomy, 62
Trans-corneal, 153, 155, 157
Transfection, 174, 177, 179 Transferase, 227, 228 Transferrin, 3
Transgenic, 86, 89, 99, 156, 157, 158, 167, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180
Trans-scleral, 33, 153, 157 TRITC, 237
Trituration, 6
Trophic factor, 129, 235 Trophic withdrawal, 235 Tropicamide, 52, 113, 134, 268 Trusopt (dorzolamide), 50, 51 Trypsin, 6, 8, 9
TUNEL, 118, 120, 227
Tween, 231, 232, 237
Ultrastructure, 43, 168
Ultrathin, 192, 201
Undersampling, 195
UniBlitz shutter, 244
Uveoscleral, 49, 57, 60
Valinomycin, 246 Vanadate, 62 Vannas scissors, 34
Vasoconstriction, 155 Vasodilation, 155 Vectastain, 213
Venous plexus, 24, 25, 27, 33 VERIS, 268, 274
Vervet, 48
vesicular stomatitis virus (VSV), 179 Vibratome, 7
Virion, 177, 179 Viscoelastic, 61, 69
Visual evoked potential (VEP), 18, 57, 298 Vitrectomy, 110, 111, 114, 117, 122 Vitreoretinal, 117, 122 Vitreoretinopathy, 110, 111, 119
322
Vitreous, 5, 18, 19, 53, 61, 110, 111, 112, 113, 114, 116, 117, 119, 122, 131, 136, 139, 154, 155, 156, 172, 173, 200, 209, 210, 218
Vmax, 263, 264
Wistar, 23, 24, 26, 28
Index
Xalatan (latanoprost), 51, 62
XIAP, 169
Xylazine, 24, 113, 130, 136, 254
Xylene, 202, 228, 233
Xylocaine, 113
YOYO-1, 228, 230, 234, 235, 236, 237, 238
About the Editors
LEONARD A. LEVIN is Associate Professor of Ophthalmology and Visual Sciences, Neurology, and Neurological Surgery at University of Wisconsin Medical School–Madison, where he studies mechanisms of retinal ganglion cell death. He primarily focuses on the role axonal damage plays in inducing loss of retinal ganglion cells, an area common to both neuro-ophthalmology and glaucoma, and is the principal investigator on a National Eye Institute–supported grant to study this topic. Dr. Levin is a Research to Prevent Blindness Dolly Green Scholar and an associate editor of the Archives of Ophthalmology. He received the A.B. degree (1980) in applied mathematics, the Ph.D. degree (1988) in neurobiology, and the M.D. degree (1988) from Harvard University, Cambridge, Massachusetts. He did a residency in ophthalmology and a fellowship in neuro-ophthalmology at the Massachusetts Eye and Ear Infirmary.
ADRIANA DI POLO is Assistant Professor of Pathology and Cell Biology at the Universite´ de Montre´al, Quebec, Canada. A major focus of her laboratory is to develop gene therapy strategies to promote cell survival and regeneration of adult retinal ganglion cells, the neuronal population that dies in glaucoma. She received the B.Sc. degree (1989) from the Universidad Central de Venezuela, Caracas, and the Ph.D. degree (1995) from the University of California School of Medicine, Los Angeles.